Table 2.
NLRP3 activated cytokines and other major cytokines in psychiatric disorders: a list of inflammatory cytokines in the NLRP3 priming pathway sampled in patients with major depressive disorder and bipolar disorder.
| Psychiatric Disorder | Inflammatory Protein (+/−) | Sample-Type | Source |
|---|---|---|---|
| Major Depressive Disorder | (+) Il-1β | CSF | (Levine et al., 1999) |
| (+) Il-1β | Serum | (Anisman et al., 1999; Howren et al., 2009; Maes et al., 1993; Owen et al., 2001; Thomas et al., 2005) | |
| (+) IL-18 | Serum | (Kokai et al., 2002; Merendino et al., 2002), | |
| (+) Il-6 | Serum | (Howren et al., 2009; Lanquillon et al., 2000; Sluzewska, 1999) | |
| (−) Il-6 | CSF | (Levine et al., 1999) | |
| (+) TNF-α | Serum | (Anisman et al., 1999; Hestad et al., 2003; Lanquillon et al., 2000) | |
| Bipolar Disorder | (+) IL-1β | Post-Mortem Tissue | (Rao et al., 2010) |